Nouscom

Nouscom • Re-defining innovation

Rome, Italy · Founded 2015 · $82.0M raised

Headquarters
Rome
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$82.0M
Last Round
$82.0M Series CMar 2024
Rounds
3

About

Nouscom is a clinical-stage immuno-oncology company developing next-generation viral vector cancer vaccines based on neoantigens. Founded in 2015, the company's proprietary platform uses recombinant adenoviruses derived from non-human great apes (GAd) and MVA to generate potent anti-tumor immune responses, enabling both off-the-shelf and personalized cancer immunotherapies. Nouscom is headquartered in Basel, Switzerland, with research operations in Rome, Italy.

Summary

Nouscom is a Biotech company based in Rome, Italy, founded in 2015. It has raised $82.0M in total across 3 rounds, most recently a $82.0M Series C round in Mar 2024. Investors include LSP Life Sciences Partners, Versant Ventures and Angelini Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2024
$82.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nouscom on Indexed.vc
<a href="https://indexed.vc/companies/nouscom"><img src="https://indexed.vc/api/badge/company/nouscom" alt="Nouscom on Indexed.vc" width="260" height="76" /></a>